Immunovaccine Technologies

Immunovaccine Technologies is a vaccine enhancement company focused on the commercialization of its patented VacciMax(R) platform. VacciMax(R) is a new technology that can aid in the development of novel vaccines for human health applications, with potential applications in cancer therapeutics and preventive infectious disease vaccines. The opportunities for market applications and medical benefits are extensive, with current applications in cervical cancer, and potential in melanoma, breast cancer, prostate cancer, and colon cancer treatments, as well as in the prevention and treatment of influenza and other infectious diseases.